Related Experiment Video
Updated: Aug 19, 2025
A Pipeline using Bilateral In Utero Electroporation to Interrogate Genetic Influences on Rodent Behavior
Published on: May 21, 2020
How can we obtain truly translational mouse models to improve clinical outcomes in schizophrenia?
1School of Biomedical Sciences, University of Leeds, Leeds LS6 3BX, UK.
Abstract:
Schizophrenia is a serious mental illness affecting 0.7% of the world's population. Despite over 50 years of schizophrenia drug identification and development, there have been no fundamental advances in the treatment of schizophrenia since the 1980s. Complex genetic aetiology and elusive pathomechanisms have made it difficult for researchers to develop models that sufficiently reflect pathophysiology to support effective drug discovery. However, recent large-scale, well-powered genomic studies have identified risk genes that represent tractable entry points to decipher disease mechanisms in heterogeneous patient populations and develop targeted treatments. Replicating schizophrenia-associated gene variants in mouse models is an important strategy to start understanding their pathogenicity and role in disease biology. Furthermore, longitudinal studies in a wide range of genetic mouse models from early postnatal life are required to assess the progression of this disease through developmental stages to improve early diagnostic strategies and enable preventative measures. By expanding and refining our approach to schizophrenia research, we can improve prevention strategies and treatment of this debilitating disease.
Insights
Schizophrenia treatment remains stagnant despite decades of research. New genomic insights and mouse models offer hope for understanding disease mechanisms and developing targeted therapies for this serious mental illness.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Schizophrenia affects 0.7% of the global population, with no major treatment advances since the 1980s.
- Complex genetic factors and poorly understood disease mechanisms hinder effective drug discovery and development.
- Current research models often fail to adequately represent the pathophysiology of schizophrenia.
Discussion:
- Large-scale genomic studies have identified specific schizophrenia risk genes.
- These genes provide potential targets for deciphering disease mechanisms and developing personalized treatments.
- Replicating these genetic variants in mouse models is crucial for studying pathogenicity and biological roles.
Key Insights:
- Genomic studies are revolutionizing schizophrenia research by pinpointing actionable targets.
- Mouse models are essential for validating genetic findings and exploring disease biology.
- Longitudinal studies in genetic mouse models are needed to understand disease progression.
Outlook:
- Refined research approaches, including advanced mouse models and longitudinal studies, can improve early diagnosis.
- Developing targeted therapies based on genetic risk factors holds promise for more effective schizophrenia treatment.
- Enhanced understanding of schizophrenia pathophysiology can lead to improved prevention strategies and interventions.
More Related Videos
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
08:33Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
Published on: February 28, 2016
